The report presents current information (updated to September 2015) on candidate vaccines, therapies and medical devices for Ebola and gives an overview of completed and on-going trials.
This document updates the 2009 ECDC guidance on chlamydia control in Europe. It was developed by a technical expert group which conducted a critical review of the scientific evidence on the epidemiology of chlamydia and the effectiveness of screening programmes.
The aim of this guidance is to suppo...rt Member States to develop, implement or improve strategies for chlamydia control. This guidance describes the current evidence base behind the proposed options, highlights key gaps in knowledge, and suggests effective options for national chlamydia control strategies. It is directed primarily at policy advisors but should also be useful for programme managers and experts in sexual health.
more
The guidebook can be used by any care giver who comes in contact with children on a daily basis and who have the primary or secondary responsibility of taking care of the children. Parents, teachers, anganwadi workers, child care institutions, hospitals can use this guide-book to help a child who is... in need of care and protection. This guidebook can also be used by those who meet a child by accident who is in need of protection immediately. They can follow the steps mentioned in the guidebook that can be followed to help the child in need
more
This policy discussion paper is designed to give an overview of the legal and policy implications of the dealat the present time.This paper is not designed to be an exhaustive statement or exploration of all issues –rather, its purpose is to highlight the key policy and legal challenges which the ...EU-Turkey Deal has created at this early stage from the perspective of forced migrants.
more
A short Guide for Health Practitioners
There is an urgent need for safer, simpler, more efficacious and accessible treatment regimens for all forms of TB. The development of Target Product Profiles for TB treatment regimens (referred to as Target Regimen Profiles or TRPs) seeks to guide the drug development process towards important regi...men characteristics corresponding to the needs of end-users.
more
The World Health Organization was requested by Member States to develop a global priority pathogens list (global PPL) of antibiotic-resistant bacteria to help in prioritizing the research and development (R&D) of new and effective antibiotic treatments. To date, the selection of pathogens for R&D ac...tivities has been largely guided by small and large pharmaceutical companies according to a variety of parameters, such as perceived/unmet medical need, pressure of investors, market size, scientific discovery potential, and availability of specific technologies. Previous PPLs, issued by the Centers for Disease Control and Prevention.
more
A Technical Paper. Final Report